Expression of target molecules in lung cancer: Challenge for a new treatment paradigm

Keyphrases

• Lung Cancer 100%
• Target Molecule 100%
• Treatment Paradigms 100%
• Monoclonal Antibody 50%
• United States 50%
• Early Detection 50%
• Cell Apoptosis 50%
• Recent Advances 50%
• Growth Factors 50%
• T Cells 50%
• Fatality 50%
• Small Molecule Inhibitors 50%
• Cell Proliferation 50%
• New Therapeutics 50%
• Therapeutic Potential 50%
• Tumor Cells 50%
• Angiogenesis 50%
• Cancer Mortality 50%
• Metastasis 50%
• Ribozyme 50%
• Antisense Molecules 50%
• Metastatic Disease 50%
• Cancer Causes 50%
• Survival Rate 50%
• Novel Therapies 50%
• Chemoprevention 50%
• Lung Cancer Treatment 50%
• Presentation Time 50%
• New Therapeutic Strategies 50%
• Cell Growth 50%
• Tumor-specific 50%
• Lung Cancer Patients 50%
• Surface Antigen 50%
• Chemotherapy Treatment 50%
• All Cancer 50%
• Lung Carcinogenesis 50%
• Immunotoxin 50%
• Local Environment 50%
• Specific Immunity 50%
• Specific Survival 50%
• Lung Cancer Biology 50%
• Combined Treatment Modalities 50%
• State Accounting 50%

Medicine and Dentistry

• Lung Cancer 100%
• Metastatic Carcinoma 66%
• Malignant Neoplasm 33%
• Monoclonal Antibody 33%
• Programmed Cell Death 33%
• Angiogenesis 33%
• Survival Rate 33%
• Receptor 33%
• Fatality 33%
• Growth Factor 33%
• Cancer Mortality 33%
• Adaptive Immunity 33%
• T Cell 33%
• Tumor Cell 33%
• Specific Tumor 33%
• Cell Growth 33%
• Membrane Antigen 33%
• Treatment of Lung Cancer 33%
• Chemoprevention Strategy 33%
• Lung Carcinogenesis 33%
• Ribozyme 33%
• Antisense Molecule 33%
• Immunotoxin 33%
• Chemotherapy 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Lung Cancer 100%
• Neoplasm 50%
• Malignant Neoplasm 25%
• Monoclonal Antibody 25%
• Chemotherapy 25%
• Ribozyme 25%
• Receptor 25%
• Antisense Molecule 25%
• Growth Factor 25%
• Cancer Mortality 25%
• Survival Rate 25%
• Metastasis 25%
• Fatality 25%
• Membrane Antigen 25%
• Lung Carcinogenesis 25%
• Immunotoxin 25%